My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Three stocks decline ex-dividend
Jul 04,2017

Meanwhile, the S&P BSE Sensex was up 58.66 points or 0.19% at 31,280.28.

Sundaram Finance fell 2.11% to Rs 1,620 as the stock turned ex-dividend today, 4 July 2017, for final dividend of Rs 6.50 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.39% based on the closing price of Rs 1,654.85 on BSE yesterday, 3 July 2017.

Essel Propack lost 2.01% to Rs 241.80 as the stock turned ex-dividend today, 4 July 2017, for final dividend of Rs 2.40 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.97% based on the closing price of Rs 246.75 on BSE yesterday, 3 July 2017.

CCL Products (India) lost 1.52% to Rs 298 as the stock turned ex-dividend today, 4 July 2017, for dividend of Rs 2.50 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.83% based on the closing price of Rs 302.60 on BSE yesterday, 3 July 2017.

Powered by Capital Market - Live News

Indian Metals & Ferro Alloys to hold board meeting
Jul 04,2017

Indian Metals & Ferro Alloys will hold a meeting of the Board of Directors of the Company on 17 July 2017 to consider and take on record, inter-alia, the unaudited financial results of the Company for the quarter ended 30th June, 2017.

Powered by Capital Market - Live News

Sun Pharma enters into strategic agreement with Samsung BioLogics
Jul 04,2017

Sun Pharmaceutical Industries and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. Theagreement was entered into by Sun Pharmas wholly-owned subsidiary and Samsung BioLogics.

According to the agreement, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. Filings for this novel investigational biologic has been accepted for review by the U.S. Food and Drug Administration (FDA) (May2017) and the European Medicines Agency (EMA) (March 2017). The agreement was signed at Samsung BioLogics headquarter in Incheon, South Korea. The approximate value of the contract will be US$ 55.5 million, other financial details of the agreement are confidential.

Powered by Capital Market - Live News

Shares of GTPL Hathway get listed
Jul 04,2017

The equity shares of GTPL Hathway (Scrip Code: 540602) are listed effective 04 July 2017 and admitted to dealings on the Exchange in the list of B Group Securities.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals receives final approval for Maloff Protect (anti-malerial medication)
Jul 04,2017

Glenmark Pharmaceuticals Europe has been granted final approval by the MHRA (Medicines and Healthcare products Regulatory Agency) for Maloff Protect (250mg/100mg atovaquone/proguanil film-coated tablets), anti-malarial medication, as a pharmacy license in the United Kingdom.

Maloff Protect will be used in the prevention of malaria in adults travelling to areas where malaria is prevalent. Maloff Protect contains atovaquone and proguanil hydrochloride, and has been available only as a prescription medicine in the UK. Under this approval, patients will be able to purchase Maloff Protect without a prescription.

Powered by Capital Market - Live News

ICICI Bank provides update on proposed IPO of ICICI Lombard GIC
Jul 04,2017

ICICI Bank announced the termination of the joint venture agreement with Fairfax Finanacial Holdings on 03 July 2017. This termination agreement relates to approval of sale of a part of ICICI Bank shareholding in ICICI Lombard General Insurance Company (the Company) in an initial public offering proposed to be undertaken by the Company. The Termination Agreement has customary provisions for protection of parties in the event of non-completion of the proposed initial public offering on or before a mutually agreed date.

Powered by Capital Market - Live News

Wockhardt gains after getting USFDA OK for generic eye drops
Jul 04,2017

The announcement was made after market hours yesterday, 3 July 2017.

Meanwhile, the S&P BSE Sensex was up 29.49 points, or 0.09% to 31,251.11.

On the BSE, 31,000 shares were traded in the counter so far, compared with average daily volumes of 1.65 lakh shares in the past one quarter. The stock had hit a high of Rs 615.30 and a low of Rs 606.50 so far during the day. The stock hit a 52-week high of Rs 1,129 on 21 July 2016. The stock hit a 52-week low of Rs 555 on 22 June 2017.

The stock had underperformed the market over the past one month till 3 July 2017, falling 3.49% compared with 0.17% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 20.93% as against Sensexs 4.38% rise. The scrip had also underperformed the market in past one year, falling 36.48% as against Sensexs 14.45% rise.

The mid-cap company has equity capital of Rs 55.28 crore. Face value per share is Rs 5.

Wockhardt said it has received final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for 0.1% ophthalmic solution of Olopatadine HCI. The eye drop Olopatadine HCI 0.1% ophthalmic solution is a generic version of Patanol, marketed in the United States by Alcon, a subsidiary of Novartis. The product will be manufactured at a USFDA approved contract manufacturing organization, based in Montreal, Canada.

Wockhardt reported consolidated net loss of Rs 174.72 crore in Q4 March 2017, sharply higher than net loss of Rs 5.38 crore in Q4 March 2016. Wockhardts consolidated net sales fell 14.5% to Rs 863.53 crore in Q4 March 2017 over Q4 March 2016.

Wockhardt is a global pharmaceutical and biotech company with presence in USA, UK, Ireland, Mexico, Russia and many other countries.

Powered by Capital Market - Live News

With The Roll-Out of GST, Check Posts Get Abolished Across 22 States in India
Jul 04,2017

The Goods and Services Tax (GST) was rolled out on 1st of July 2017. With the roll-out of the GST, 22 States in India have abolished their check posts. The details are as under -

1. Andhra Pradesh

2. Arunachal Pradesh

3. Bihar

4. Gujarat

5. Karnataka

6. Kerala

7. Madhya Pradesh

8. Maharashtra

9. Sikkim

10. Tamil Nadu

11. West Bengal

12. Chhattisgarh

13. Delhi

14. Goa

15. Haryana

16. Jharkhand

17. Odisha

18. Puducherry

19. Rajasthan

20. Telangana

21. Uttar Pradesh

22. Uttarakhand

States where check posts are in the process of being abolished

1. Assam

2. Himachal Pradesh

3. Manipur

4. Meghalaya

5. Nagaland

6. Punjab

7. Mizoram

8. Tripura

Powered by Capital Market - Live News

MoU Signed between Department of Defence Production and MDL
Jul 04,2017

Mazagon Dock Shipbuilders Ltd (MDL), a Miniratna Schedule A DPSU under the Department of Defence Production, Ministry of Defence signed a Memorandum of Understanding (MoU) for the financial year 2017-18 with the Ministry. The annual MoU was signed between Secretary (Defence Production) Shri AK Gupta on behalf of the Ministry and Chairman and Managing Director, MDL Cmde Rakesh Anand. The MoU outlines the targets and various performance parameters for the company. The revenue from operations has been targeted at 4500 crore. Significant milestones to be achieved under Project 75 (Scorpene Submarines) and shipbuilding projects of 15B (destroyers) and 17A (frigates) also form part of the MoU.

Powered by Capital Market - Live News

Ambuja Cements in focus after securing limestone block in Maharashtra
Jul 04,2017

Ambuja Cements said it has participated in the e-auction tender of limestone block for Nandgaon Ekodi Limestone block in Chandrapur district of Maharashtra by the state government of Maharashtra. The company has secured an estimated limestone of 42 million tones at a final bid price of 125.05% of value of mineral dispatched. The company is expecting a formal communication vesting the said block in its favour shortly, it said. The announcement was made after market hours yesterday, 3 July 2017.

YES Bank said its board will meet on 26 July 2017 to consider stock split. The announcement was made after market hours yesterday, 3 July 2017.

Sun Pharmaceutical Industries and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharmas wholly-owned subsidiary and Samsung BioLogics. According to the agreement, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. Filings for this novel investigational biologic has been accepted for review by the U.S. Food and Drug Administration (FDA) (May 2017) and the European Medicines Agency (EMA) (March 2017). The agreement was signed at Samsung BioLogics headquarter in Incheon, South Korea. The approximate value of the contract will be $55.5 million, other financial details of the agreement are confidential. The announcement was made before trading hours today, 4 July 2017.

Wockhardt said it has received final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for 0.1% ophthalmic solution of Olopatadine HCI. The eye drop Olopatadine HCI 0.1% ophthalmic solution is a generic version of Patanol, marketed in the United States by Alcon, a subsidiary of Novartis.

The product will be manufactured at a USFDA approved contract manufacturing organization, based in Montreal, Canada. The announcement was made after market hours yesterday, 3 July 2017.

JSW Steel said it has received shareholders approval to raise over Rs 14,000 crore through various securities. The announcement was made after market hours yesterday, 3 July 2017.

Shareholders during the companys annual general meeting gave consent for private placement of redeemable non- convertible debentures aggregating up to Rs 10000 crore. Besides, an approval was also given for issuance of non-convertible debentures with warrants for an amount not exceeding Rs 4000 crore and/or issue of equity shares or fully, partly or optionally convertible debentures or any other convertible securities (other than warrants).

Jindal Poly Films said it will acquire Netherlands-based Apeldoorn Flexible Packaging Holding BV through its subsidiary in an all-cash deal, marking its foray into the load security films market. The announcement was made after market hours yesterday, 3 July 2017.

Powered by Capital Market - Live News

Ambuja Cements secures limestone resources of 42 million
Jul 03,2017

Ambuja Cements participated in the e-auction of limestone block for Nandgaon Ekodi Limestone Block in Chandrapur district of Maharashtra by the State Government of Maharashtra. The Company has secured an estimated limestone resource of 42 million at a final bid price of 125.05% of value of mineral dispatched. The Company is expecting a formal communication vesting the said block in its favour shortly.

Powered by Capital Market - Live News

NTPC declares commercial operation of 2nd Unit of Muzaffarpur Thermal Power Station
Jul 03,2017

NTPC announced that 2nd Unit of 195 MW of Muzaffarpur Thermal Power Station Stage-II (2 X 195 MW) of Kanti Bijlee Utpadan Nigam (a subsidiary of NTPC) is declared on commercial operation w.e.f 00:00 Hrs. of 01 July 2017.

With this, the commercial capacity of Muzaffarpur Thermal Power Station has become 610 MW and that of NTPC group has become 47488 MW.

Powered by Capital Market - Live News

Frontline Corporation intimates of extension of transportation contract in Karnataka
Jul 03,2017

Frontline Corporation announced that Hindustan Coco-Cola Beverage has extended Transportation Contract for transportation of goods in the state of Karnataka, by two months ended on 31 August 2017.

Powered by Capital Market - Live News

Frontline Corporation intimates of renewal of transportation contract in Maharashtra
Jul 03,2017

Frontline Corporation announced that Hindustan Coco-Cola Beverage has renewed Transportation Contract for transportation of goods in the state of Maharashtra, for nine months ended on 31 December 2017.

Powered by Capital Market - Live News

Jyoti Structures announces resignation of director
Jul 03,2017

Jyoti Structures announced that Kalpesh Kilani, Director of the Company has resigned with effect from 23 June 2017.

Powered by Capital Market - Live News